Loading...
Crizanlizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting SELP,
Biosimilars
Human
Monoclonal
Human
SELP
Human
IgG2 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1690318-25-2
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más